Apogem Capital’s Darling Ingredients DAR Stock Holding History

Apogem Capital’s Portfolio DAR Stock Details DAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-20,726	Closed	-$1.2M	–	188
2020 Q4	$1.2M	Buy	+20,726	New	+$990K	0.8%	40

Other funds holding DAR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Apogem Capital's DAR Position: Q1 2021 in Review

Apogem Capital sold out of Darling Ingredients (DAR) in Q1 2021, closing a stake of 20,726 shares — an estimated $1.2M sold.

Apogem Capital first reported a position in DAR in Q4 2020 and held it in 1 quarter. The position peaked at $1.2M in Q4 2020. 416 funds tracked by Wall St. Rank hold DAR as of Q1 2021.

Apogem Capital reported no remaining Darling Ingredients position as of Q1 2021 after selling out during the quarter.
Apogem Capital sold 20,726 Darling Ingredients shares in Q1 2021, an estimated $1.2M.
Apogem Capital first reported a position in Darling Ingredients in Q4 2020 and held it in 1 quarter.
Apogem Capital's Darling Ingredients position peaked at $1.2M in Q4 2020.
416 funds tracked by Wall St. Rank held Darling Ingredients as of Q1 2021.

Based on Apogem Capital's 13F filing for Q1 2021, filed 14 May 2021.